BGM — BGM Group Ltd.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1779578 ·
China
Last close
$0.24
Market Cap
$91.35M
52W High
$10.68
52W Low
$0.23
ADV30
239,413
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | 436,546,938 | 11,517,115 | 44,649,445 |
| Sep 2025 | — | — | — | — | 433,814,485 | 9,819,570 | 41,916,992 |
| Mar 2025 | — | — | — | — | 207,393,449 | 9,651,606 | 23,902,462 |
| Sep 2024 | — | — | — | — | 53,003,728 | 9,817,254 | 8,910,379 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-15,777,045
Inventory
$20,103,215
Receivables
$17,049,516
ST Investments
$994,895
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$47,903,456
EBITDA
$-9,248,076
Free Cash Flow
$11,236,709
Enterprise Value
$43,922,940
Total Cash
$11,545,513
Total Debt
$1,175,106
Shares Out
380,623,358
Trailing EPS
$-0.16
Book Value
$1.99
ROE
-7.4%
ROA
-2.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 37,919,425 | -12,449,402 | -19,941,242 | 433,814,485 | 41,916,992 | 390,878,117 | -2,372,437 |
| Sep 2024 | 25,097,951 | -357,356 | -1,442,830 | 53,003,728 | 8,910,379 | 42,743,844 | 544,238 |
| Sep 2023 | 46,471,478 | -2,417,724 | -7,780,620 | 51,257,994 | 6,906,593 | 42,792,133 | 312,209 |
| Sep 2022 | 64,855,025 | 2,515,720 | 1,076,693 | 64,526,617 | 9,563,081 | 53,052,142 | 12,654,188 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ACRV | Acrivon Therapeutics, Inc. | $89.99M | $2.10 | — |
| RLYB | Rallybio Corp | $88.26M | $16.62 | — |
| RANI | Rani Therapeutics Holdings, Inc. | $87.61M | $0.76 | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | $95.35M | $3.31 | — |
| BMEA | Biomea Fusion, Inc. | $95.44M | $1.32 | — |
News headlines (Yahoo Finance, 1h cache)
BGM Group Ltd. Receives NASDAQ Notice Related to Late Filing of Form 20-F
2026-02-26 21:15 · Yahoo
BGM Group Ltd. (BGM) Surges 35% as AI, Biopharma Transformation Gains Investor Attention
2025-10-01 17:41 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.